Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease (IVR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00449852 |
Recruitment Status
:
Completed
First Posted
: March 21, 2007
Last Update Posted
: April 29, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Coronary Artery Disease | Behavioral: Interactive Voice Response | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 442 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Official Title: | An Interactive, Voice Response-Mediated, Follow-up and Triage System for Smoking Cessation in Smokers With Coronary Heart Disease |
Study Start Date : | July 2006 |
Actual Primary Completion Date : | February 2011 |
Actual Study Completion Date : | February 2011 |
Arm | Intervention/treatment |
---|---|
Experimental: Interactive Voice Response Group |
Behavioral: Interactive Voice Response
The IVR group will receive a telephone call from the IVR system three, 14, 30, 90, 120 and 150 days after hospital discharge.
|
No Intervention: Usual Care Group |
- Biochemically confirmed 7-day point prevalent smoking abstinence [ Time Frame: 52 weeks ]
- Use of smoking cessation resources [ Time Frame: 26 & 52 weeks ]
- Self-efficacy in regards to smoking cessation [ Time Frame: 26 & 52 weeks ]
- Patient Satisfaction of the IVR system [ Time Frame: 26 weeks ]
- Continuous Abstinence since hospitalization [ Time Frame: 52 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 90 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient is currently a smoker (greater than 5 cigarettes per day in the month preceding admission);
- Patient is 18 years of age and older;
- Patient is admitted to the in-patient cardiology service at the University of Ottawa Heart Institute (UOHI) for: a) Acute Coronary Syndrome (includes patients admitted for unstable angina or acute myocardial infarction), b) Elective Percutaneous Coronary Intervention (PCI), c) Coronary Artery Bypass Graft (CABG) or d) diagnostic catheterization procedures related to CHD;
- Patient has received automatic referral for smoking cessation counseling;
- Patient is willing to provide informed consent
Exclusion Criteria:
- Patient is unable to read and understand English;
- Patient lives more than 1.5 hours from UOHI;
- Patient is returning to referring institution/hospital

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00449852
Canada, Ontario | |
University of Ottawa Heart Institute | |
Ottawa, Ontario, Canada, K1Y4W |
Study Chair: | Robert D Reid, PhD. | University of Ottawa Heart Institute, Minto Prevention and Rehabilitation Centre | |
Principal Investigator: | Andrew Pipe, C.M, MD | University of Ottawa Heart Institute, Minto Prevention and Rehabilitation Centre | |
Principal Investigator: | Bonnie Quinlan, BSCN | University of Ottawa Heart Institute, Prevention and Rehabilitation Centre | |
Principal Investigator: | Heather Sherrard, BSCN, MHA | Ottawa Heart Institute Research Corporation |
Responsible Party: | Robert Reid PhD MBA, University of Ottawa Heart Institute |
ClinicalTrials.gov Identifier: | NCT00449852 History of Changes |
Other Study ID Numbers: |
NA 5845 |
First Posted: | March 21, 2007 Key Record Dates |
Last Update Posted: | April 29, 2011 |
Last Verified: | April 2011 |
Keywords provided by Ottawa Heart Institute Research Corporation:
Randomized Control Trial Smoking Cessation Secondary Prevention Rehabilitation Counseling |
Additional relevant MeSH terms:
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |